Xponance’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.79M | Sell |
86,784
-7,934
| -8% | -$621K | 0.06% | 261 |
|
|
2025
Q1 | $6.87M | Sell |
94,718
-370
| -0.4% | -$26.8K | 0.07% | 239 |
|
|
2024
Q4 | $7.04M | Buy |
95,088
+1,675
| +2% | +$124K | 0.06% | 232 |
|
|
2024
Q3 | $6.16M | Buy |
93,413
+1,120
| +1% | +$73.9K | 0.06% | 250 |
|
|
2024
Q2 | $8.53M | Sell |
92,293
-46,106
| -33% | -$4.26M | 0.09% | 175 |
|
|
2024
Q1 | $13.2M | Sell |
138,399
-578
| -0.4% | -$55.2K | 0.14% | 127 |
|
|
2023
Q4 | $10.6M | Sell |
138,977
-2,186
| -2% | -$167K | 0.13% | 135 |
|
|
2023
Q3 | $9.78M | Buy |
141,163
+2,273
| +2% | +$157K | 0.13% | 131 |
|
|
2023
Q2 | $13.1M | Sell |
138,890
-387
| -0.3% | -$36.5K | 0.17% | 101 |
|
|
2023
Q1 | $11.5M | Buy |
139,277
+2,379
| +2% | +$197K | 0.17% | 114 |
|
|
2022
Q4 | $10.2M | Buy |
136,898
+9,334
| +7% | +$696K | 0.17% | 117 |
|
|
2022
Q3 | $10.5M | Buy |
127,564
+2,265
| +2% | +$187K | 0.2% | 93 |
|
|
2022
Q2 | $11.9M | Sell |
125,299
-10,586
| -8% | -$1.01M | 0.24% | 72 |
|
|
2022
Q1 | $16M | Buy |
135,885
+1,395
| +1% | +$164K | 0.27% | 70 |
|
|
2021
Q4 | $17.4M | Buy |
134,490
+9,052
| +7% | +$1.17M | 0.27% | 63 |
|
|
2021
Q3 | $14.2M | Sell |
125,438
-2,995
| -2% | -$339K | 0.27% | 71 |
|
|
2021
Q2 | $13.3M | Sell |
128,433
-4,270
| -3% | -$442K | 0.24% | 72 |
|
|
2021
Q1 | $11.1M | Buy |
132,703
+41,596
| +46% | +$3.48M | 0.24% | 79 |
|
|
2020
Q4 | $8.31M | Sell |
91,107
-39,682
| -30% | -$3.62M | 0.18% | 100 |
|
|
2020
Q3 | $10.4M | Sell |
130,789
-8,509
| -6% | -$679K | 0.26% | 73 |
|
|
2020
Q2 | $9.63M | Buy |
+139,298
| New | +$9.63M | 0.25% | 85 |
|